Position in PSNL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,911,000
New position
Shares Held
300,000
first reported quarter
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $583,875,820 across 11 Diagnostics & Research names. PSNL ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
545,832 | $268,292,802 | |
| 2 | GH |
Guardant Health, Inc.
|
816,095 | $75,382,695 | |
| 3 | DHR |
Danaher Corp /De/
|
376,027 | $71,294,719 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
256,009 | $44,161,552 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
68,301 | $38,377,648 | |
| 6 | LH |
Labcorp Holdings Inc.
|
106,000 | $28,281,860 | |
| 7 | WAT |
Waters Corp /De/
|
87,856 | $26,163,516 | |
| 8 | QGEN |
Qiagen N.V.
|
285,000 | $11,411,400 |
All Filings in PSNL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,911,000 | 300,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||